GSK vs SLGN · P/E 13, $103.31B cap vs P/E 14, rev $3.20B
GlaxoSmithKline PLC ADR (GSK) versus Silgan Holdings Inc (SLGN) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Silgan Holdings Inc (SLGN) is a packaging & containers company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported SLGN revenue for 2026-06-30 was $3.20B. Net income was $138.8M. SLGN currently screens at market cap $3.83B and trailing P/E 13.6.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SLGN currently screens at market cap $3.83B and trailing P/E 13.6.
Not investment advice. Open the GSK and SLGN stock pages for the full models.
Not investment advice.